The AIDS Clinical Trials Group (ACTG) Network has been re-funded for the next seven years by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The ACTG is the largest global HIV research network. Dr. Joe Eron, UNC CFAR Clinical Core Director, is vice chair of the ACTG.
“Founded in 1987, the ACTG was the first clinical trial network to focus on HIV. Its mission is to cure HIV and reduce the burden of disease due to HIV and its complications, including tuberculosis and viral hepatitis. Over the course of 2020, in addition to this work, ACTG has also been leading efforts to identify effective treatments for early COVID-19 by conducting the ACTIV-2 study.”
Read more from the ACTG Press Release here, published November 30, 2020.
